These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8645080)
21. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights. Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187 [TBL] [Abstract][Full Text] [Related]
22. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland. Bhargav PR; Gayathri KB Indian J Pathol Microbiol; 2011; 54(2):414-5; author reply 415. PubMed ID: 21623114 [No Abstract] [Full Text] [Related]
23. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225 [TBL] [Abstract][Full Text] [Related]
24. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer. Xiong Y; Kotian S; Zeiger MA; Zhang L; Kebebew E PLoS One; 2015; 10(8):e0130496. PubMed ID: 26244545 [TBL] [Abstract][Full Text] [Related]
25. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation. Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533 [TBL] [Abstract][Full Text] [Related]
28. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma. Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583 [TBL] [Abstract][Full Text] [Related]
29. Blood group antigen expression in malignant tumors of the thyroid: a parallel between medullary and nonmedullary carcinomas. Larena A; Vierbuchen M; Fischer R Langenbecks Arch Chir; 1995; 380(5):269-72. PubMed ID: 7500798 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909 [TBL] [Abstract][Full Text] [Related]
34. [Correlations between cytology and histology in thyroid pathology. Case 2. Possible malignant lesion (insular carcinoma/poorly differentiated follicular carcinoma)]. Cochand-Priollet B Ann Pathol; 2009 Apr; 29(2):91-4. PubMed ID: 19364580 [No Abstract] [Full Text] [Related]